Pfizer is more than doubling the cost of COVID drug Paxlovid to $1,390 per course

Pfizer — the American pharmaceutical company that helped manufacture the COVID-19 vaccine — announced on Wednesday that it is hiking the price of its antiviral drug Paxlovid to $1,390 per course, starting in 2024. In a story first reported by The Wall Street Journal, a company spokesman confirmed that Pfizer plans on more than doubling the $529 that the federal government paid for Paxlovid....

Originally posted on salon.com